mTOR Regulates Lysosomal ATP-Sensitive Two-Pore Na+ Channels to Adapt to Metabolic State

Archive ouverte

Cang, Chunlei | Zhou, Yandong | Navarro, Betsy | Seo, Young-Jun | Aranda, Kimberly | Shi, Lucy | Battaglia-Hsu, Shyuefang | Nissim, Itzhak | Clapham, David e. | Ren, Dejian

Edité par CCSD ; Elsevier -

International audience. Survival in the wild requires organismal adaptations to the availability of nutrients. Endosomes and lysosomes are key intracellular organelles that couple nutrition and metabolic status to cellular responses, but how they detect cytosolic ATP levels is not well understood. Here, we identify an endolysosomal ATP-sensitive Na+ channel (lysoNaATP). The channel is a complex formed by two-pore channels (TPC1 and TPC2), ion channels previously thought to be gated by nicotinic acid adenine dinucleotide phosphate (NAADP), and the mammalian target of rapamycin (mTOR). The channel complex detects nutrient status, becomes constitutively open upon nutrient removal and mTOR translocation off the lysosomal membrane, and controls the lysosome’s membrane potential, pH stability, and amino acid homeostasis. Mutant mice lacking lysoNaATP have much reduced exercise endurance after fasting. Thus, TPCs make up an ion channel family that couples the cell’s metabolic state to endolysosomal function and are crucial for physical endurance during food restriction.

Consulter en ligne

Suggestions

Du même auteur

Cell deconvolution-based integrated time-series network of whole blood transcriptome reveals systemic antiviral activities and cell-specific immunological changes against PRRSV infection

Archive ouverte | Lim, Byeonghwi | CCSD

International audience. AbstractPorcine reproductive and respiratory syndrome (PRRS) causes significant economic losses in the swine industry. However, the molecular mechanisms behind the common and cell type-specif...

Mitochondria control store‐operated Ca 2+ entry through Na + and redox signals

Archive ouverte | Ben‐kasus Nissim, Tsipi | CCSD

International audience

Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans

Archive ouverte | Comte, Blandine | CCSD

International audience. Phenylbutyrate is used in humans for treating inborn errors of ureagenesis, certain forms of cancer, cystic fibrosis and thalassemia. The known metabolism of phenylbutyrate leads to phenylace...

Chargement des enrichissements...